new_0222_0313|CTKB|0|total_current_assets|cash_on_hand|inventories_net|net_ppe|goodwill_and_intangible|liabilities|total_current_liabilities|total_long_term_liab|total_deposits|book_value_of_equity|retained_earnings|treasury_stock|ev_revenues|ev_earnings|ev_free_cash_flow|ev_assets|ps_ratio|pe_ratio|price_to_book_value|peg_ratio|debt_equity_ratio|dividend_yield|shareholder_yield_ttm|percent_of_shares_outstanding|receivables|payables|capital_stock|return_on_invested_capital|quality_ratio_fractile|momentum_fractile|market_beta_12_month|sustainable_growth_rate|institutional_investor_ownership_percentage|average_shares_outs_diluted|total_employee_number|eps|sga_expense|shares_outstanding|repurchase_of_capital_stock|ordinary_shares_number|payout_ratio|quick_ratio|normalized_eps|stock_buyback|effective_tax_rate|return_on_equity|net_income_ttm|revenues_ttm|dividend_per_share|revenues|gross_profit|pre_tax_income|net_income|interest_income|price|total_return_price|enterprise_value|average_volume_30|one_year_return|short_interest|forward_pe_ratio|forward_pe_ratio_1y|forward_ps_ratio|forward_ps_ratio_1y|quarterly_eps_estimates|quarterly_sales_estimates|quarterly_eps_surprise|quarterly_sales_surprise|quarterly_eps_actual|quarterly_sales_actual|sales_est_0y|sales_est_1y|price_target|consensus_recommendation|price_target_num_est|eps_est_0y|eps_est_1y|r_and_d_expense|reconciled_depreciation|interest_expense_non_operating|land_and_improvements|buildings_and_improvements|other_properties|machinery_furniture_equipment|price_next_month|price_second_month
new_0222_0313|CTKB|1|Cytek Biosciences Inc Total Current Assets (Quarterly) (USD)|Cytek Biosciences Inc Cash and Short Term Investments (Quarterly) (USD)|Cytek Biosciences Inc Inventories (Quarterly) (USD)|Cytek Biosciences Inc Net PP&E (Quarterly) (USD)|Cytek Biosciences Inc Goodwill and Intangibles (Quarterly) (USD)|Cytek Biosciences Inc Total Liabilities (Quarterly) (USD)|Cytek Biosciences Inc Total Current Liabilities (Quarterly) (USD)|Cytek Biosciences Inc Total Long Term Liabilities (Quarterly) (USD)|Cytek Biosciences Inc Total Deposits (Quarterly) (USD)|Cytek Biosciences Inc Book Value (Quarterly) (USD)|Cytek Biosciences Inc Retained Earnings (Quarterly) (USD)|Cytek Biosciences Inc Treasury Stock (Quarterly) (USD)|Cytek Biosciences Inc EV to Revenues|Cytek Biosciences Inc EV to Earnings|Cytek Biosciences Inc EV to Free Cash Flow|Cytek Biosciences Inc EV to Assets (Quarterly)|Cytek Biosciences Inc PS Ratio|Cytek Biosciences Inc PE Ratio|Cytek Biosciences Inc Price to Book Value|Cytek Biosciences Inc PEG Ratio|Cytek Biosciences Inc Debt to Equity Ratio|Cytek Biosciences Inc Dividend Yield|Cytek Biosciences Inc Shareholder Yield (TTM)|Cytek Biosciences Inc Percent of Shares Outstanding Short|Cytek Biosciences Inc Total Receivables (Quarterly) (USD)|Cytek Biosciences Inc Total Payables (Quarterly) (USD)|Cytek Biosciences Inc Total Capital Stock (Quarterly) (USD)|Cytek Biosciences Inc Return on Invested Capital|Cytek Biosciences Inc Quality Ratio Score|Cytek Biosciences Inc Momentum Score|Cytek Biosciences Inc Beta (1Y)|Cytek Biosciences Inc Sustainable Growth Rate (TTM)|Cytek Biosciences Inc Institutional Investor Ownership Percentage|Cytek Biosciences Inc Average Diluted Shares Outstanding (Quarterly)|Cytek Biosciences Inc Total Employees (Annual)|Cytek Biosciences Inc EPS Diluted (Quarterly) (USD)|Cytek Biosciences Inc SG&A Expense (Quarterly) (USD)|Cytek Biosciences Inc Shares Outstanding|Cytek Biosciences Inc Repurchase of Capital Stock (Quarterly) (USD)|Cytek Biosciences Inc Ordinary Shares Number (Quarterly)|Cytek Biosciences Inc Payout Ratio|Cytek Biosciences Inc Quick Ratio (Quarterly)|Cytek Biosciences Inc Normalized Diluted EPS (Quarterly) (USD)|Cytek Biosciences Inc Stock Buybacks (Quarterly) (USD)|Cytek Biosciences Inc Effective Tax Rate (TTM)|Cytek Biosciences Inc Return on Equity|Cytek Biosciences Inc Net Income (TTM) (USD)|Cytek Biosciences Inc Revenue (TTM) (USD)|Cytek Biosciences Inc Dividend Per Share (Quarterly) (USD)|Cytek Biosciences Inc Revenue (Quarterly) (USD)|Cytek Biosciences Inc Gross Profit (Quarterly) (USD)|Cytek Biosciences Inc Pre-Tax Income (Quarterly) (USD)|Cytek Biosciences Inc Net Income (Quarterly) (USD)|Cytek Biosciences Inc Net Interest Income (Quarterly) (USD)|Cytek Biosciences Inc Price (USD)|Cytek Biosciences Inc Total Return Price (USD)|Cytek Biosciences Inc Enterprise Value (USD)|Cytek Biosciences Inc 30-Day Average Daily Volume|Cytek Biosciences Inc 1 Year Price Returns (Daily)|Cytek Biosciences Inc Short Interest|Cytek Biosciences Inc PE Ratio (Forward)|Cytek Biosciences Inc PE Ratio (Forward 1y)|Cytek Biosciences Inc PS Ratio (Forward)|Cytek Biosciences Inc PS Ratio (Forward 1y)|Cytek Biosciences Inc Quarterly EPS Estimates (USD)|Cytek Biosciences Inc Quarterly Revenue Estimates (USD)|Cytek Biosciences Inc Quarterly EPS Surprise|Cytek Biosciences Inc Quarterly Revenue Surprise|Cytek Biosciences Inc Quarterly Actual EPS (USD)|Cytek Biosciences Inc Quarterly Actual Revenue (USD)|Cytek Biosciences Inc Revenue Estimates for Current Fiscal Year (USD)|Cytek Biosciences Inc Revenue Estimates for Next Fiscal Year (USD)|Cytek Biosciences Inc Price Target (USD)|Cytek Biosciences Inc Consensus Recommendation|Cytek Biosciences Inc Price Target Num Estimates|Cytek Biosciences Inc EPS Estimates for Current Fiscal Year (USD)|Cytek Biosciences Inc EPS Estimates for Next Fiscal Year (USD)|Cytek Biosciences Inc Research and Development Expense (Quarterly) (USD)|Cytek Biosciences Inc Reconciled Depreciation (Quarterly) (USD)|Cytek Biosciences Inc Non-Operating Interest Expense (Quarterly) (USD)|Cytek Biosciences Inc Land and Improvements (Quarterly) (USD)|Cytek Biosciences Inc Buildings and Improvements (Quarterly) (USD)|Cytek Biosciences Inc Other Properties (Quarterly) (USD)|Cytek Biosciences Inc Machine, Furniture & Equipment (Quarterly) (USD)||
new_0222_0313|CTKB|2|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|percent_USD_metric|percent_USD_metric|percent_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|percent_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_beta|percent_USD_metric|percent_USD_metric|mil_figure_USD_metric|figure_whole_USD_metric|figure_money_USD_per_share_metric|mil_figure_money_USD_metric|mil_figure_USD_metric|mil_figure_money_USD_metric|mil_figure_USD_metric|percent_USD_metric|figure_USD_metric|figure_money_USD_per_share_metric|mil_figure_money_USD_metric|percent_USD_metric|percent_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|figure_money_USD_per_share_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|figure_money_USD_price|figure_money_USD_price|mil_figure_money_USD_metric|figure_USD_metric|percent_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_money_USD_per_share_metric|mil_figure_money_USD_metric|percent_USD_per_share_metric|percent_USD_metric|figure_money_USD_per_share_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|figure_money_USD_price|figure_USD_metric|figure_whole_USD_price|figure_money_USD_per_share_metric|figure_money_USD_per_share_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric||
new_0222_0313|CTKB|4|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|daily|quarterly|daily|quarterly|daily|daily|daily|quarterly|quarterly|daily|quarterly|monthly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|monthly|quarterly|quarterly|quarterly|quarterly|monthly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|daily|daily|daily|daily|quarterly|monthly|daily|daily|daily|daily|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|monthly|monthly|monthly|monthly|monthly|monthly|monthly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly||
new_0222_0313|CTKB|5|91|91|91|91|91|91|91|91||91|91||1.43835616438||1.43835616438||1.43835616438|1.43835616438|1.4387755102||91|1.43835616438||15.4166666667|91|91|91||92||||30.6666666667|91.3333333333|91.5|91.3333333333|91.3333333333|21.8||91|91|91|91.3333333333|91.25|91||91|91||91.3333333333|91.3333333333|91.3333333333|91.3333333333|91.3333333333|1.43835616438|1.43835616438|1.43835616438|1.44444444444||15.4166666667|1.44117647059|1.44117647059|1.44117647059|1.44117647059|91.5|91.5||92|92|92|30.3333333333|30.3333333333|36.4|26|36.4|26|36.4|91.3333333333|91.3333333333|91.3333333333|||91|91||
new_0222_0313|CTKB|6|3|3|3|3|3|3|3|3||3|3||146||146||146|146|98||3|146||12|3|3|3||1||||6|6|2|6|6|5||3|3|3|6|4|3||3|3||6|6|6|6|6|146|146|146|117||12|34|34|34|34|6|6||1|1|1|6|6|5|7|5|7|5|6|6|6|||3|3||
new_0222_0313|CTKB|7|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|daily|quarterly|daily|quarterly|daily|daily|daily|daily|quarterly|daily|quarterly|daily|quarterly|quarterly|quarterly|quarterly|quarterly|monthly|monthly|quarterly|monthly|quarterly|yearly|quarterly|quarterly|daily|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|market_daily|market_daily|daily|market_daily|market_daily|daily|daily|daily|daily|daily|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|daily|daily|daily|daily|daily|daily|daily|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly||
new_0222_0313|CTKB|202003||||||||||||||||||||||||||||||||||123.0259||-0.0071|6.069||||||-0.0071|||||||17.988|8.375|-0.661|-0.839|0.086||||||||||||||||||||||||3.016|0.105|||||||
new_0222_0313|CTKB|202006||||||||||||||||||||||||||||||||||123.0259||0.0154|5.572||||||0.0659|||||||19.136|8.27|0.192|8.111|0.015||||||||||||||||||||||||2.916|0.161|0.001||||||
new_0222_0313|CTKB|202009||||||||||||||||||||||||||||||||||123.0259||0.0118|5.529||||||0.0532|||||||25.096|15.616|6.897|6.54|0.001||||||||||||||||||||||||3.376|0.179|0.002||||||
new_0222_0313|CTKB|202012|208.622|165.231|23.018|2.14|0.75|236.007|26.536|209.471||-16.028|-22.607||||||||||-0.1729||||18.104|3.978|0.023|||||||123.0259||0.1363|7.188|||130.8089||6.9089|0.0455||-34.5184||19.411|92.839||30.619|19.449|8.002|5.599|-0.325||||||||||||||||||||||||4.385|0.158|0.33|||1.396|0.57||
new_0222_0313|CTKB|202103|212.537|168.584|26.218|2.476|0.75|239.021|27.764|211.257||-15.072|-22.505||||||||||-0.1839||||15.513|4.329|0.024|||||||123.0259|391|0.0008|8.26|||130.8089||6.6308|0.0008||-33.517||20.352|99.123||24.272|14.486|0.152|0.102|-0.365||||||||||||||||||||||||5.094|0.167|0.375|||1.551|0.739||
new_0222_0313|CTKB|202106|216.938|159.846|26.655|3.895|0.809|241.264|28.165|213.099||-11.3|-19.835||24.8364||291.1863||25.1087|148.962||||||0.0097|25.476|4.277|0.024||7||||9.3707|130.8089|429||9.74|130.8089||130.8089||6.5799|0.0204||18.5992||14.911|110.395||30.408|19.745|3.267|2.67|-0.424|22.18|22.18|2741.8104|||12700||||||28.2723||7.5539||30.408|120.9368|158.4393|27.3333|2|3|0.0667|0.1033|6.194|0.201|0.433|||1.957|0.709|22.78|
new_0222_0313|CTKB|202109|439.826|376.771|27.511|4.982|0.837|51.125|30.014|21.111||402.88|-18.415||20.778|253.9691|329.2653|5.4733|21.9377|152.7235|7.1065||||-7.5335|0.4401|30.823|5.069|0.125|10.6723|5|||10.8644|32.0355|113.6374|462|0.003|12.302|133.7257||133.7257||13.5801|0.003|-215.689|27.4526|10.8644|9.791|119.675||34.376|21.277|2.075|1.42|-0.429|21.41|21.41|2486.6112|374510.1333||588524|||||0.0233|33.3715|-39.9914|3.0101|0.014|34.376|122.599|159.2636|27|2|2|0.1|0.1133|6.078|0.189|0.441|||2.146|0.79|22.81|20.17
new_0222_0313|CTKB|202112|||||||||||||15.0905||239.1354||16.7222|116.4151|5.417|||||0.7103|||||||||32.1638||||||||||||||||||||||16.32|16.32|1805.9507|229054.6||949917|197.8182|112.5517|13.6026|10.3627|0.025|36.42|||||125.4204|210.6021|25|2|3|0.1075|0.145||||||||14.56|13.93
new_0222_0313|CTKB|202203|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||0.0125|36.495||||||||||||||||||||
new_0222_0313|CTKB|202206|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||0.02|38.8443||||||||||||||||||||
new_0222_0313|CTKB|202209|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||0.025|41.1893||||||||||||||||||||
new_0222_0313|CTKB|202212|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||0.0233|44.15||||||||||||||||||||